The break-even point: When medical advances are less important than improving the fidelity with which they are delivered

Annals of Family Medicine

Volumn 3, Issue 6, 2005, Pages 545-552

  Woolf, Steven H ^a,b   Johnson, Robert E ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Allocation of resources; Delivery of health care; Disparities; Priority setting; Quality of health care

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; ATORVASTATIN; CLOPIDOGREL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PRAVASTATIN; ROSUVASTATIN; SIMVASTATIN; TICLOPIDINE;

CLINICAL TRIAL; CORONARY ARTERY DISEASE; HEALTH CARE; HEALTH CARE DELIVERY; HEALTH CARE QUALITY; HEALTH SERVICE; HUMAN; MEDICAL DECISION MAKING; MORTALITY; OUTCOME ASSESSMENT; REVIEW; STATISTICAL SIGNIFICANCE; STROKE;

BIOTECHNOLOGY; DELIVERY OF HEALTH CARE; DRUG THERAPY; HEALTH PRIORITIES; HUMANS; QUALITY OF HEALTH CARE; RESOURCE ALLOCATION; TREATMENT OUTCOME;

EID: 31544471161     PISSN: 15441709     EISSN: 15441717     Source Type: Journal    
DOI: 10.1370/afm.406     Document Type: Review

References (76)

1. McGlynn EA, Asch SM, Adams J, et al. The quality of health care delivered to adults in the United States. N Engl J Med. 2003;348:2635-2645.
2. Smedley BD, Stith AY, Nelson AR, eds. Committee on Understanding and Eliminating Racial and Ethnic Disparities in Health Care BoHSP, Institute of Medicine. Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care. Washington, DC: National Academies Press; 2003.
3. Berwick DM. A primer on leading the improvement of systems. BMJ. 1996;312:619-622.
4. Von Korff M, Gruman J, Schaefer J, Curry SJ, Wagner EH. Collaborative management of chronic illness. Ann Intern Med. 1997;127:1097-1102.
5. Berwick DM. Improvement, trust, and the healthcare workforce. Qual Saf Health Care. 2003;12:448-452.
6. Pharmaceutical Research and Manufacturers of America. Washington, DC. Pharmaceutical R&D spending: PhRMA Annual Membership Survey, 2002. 2002. Available at: http://www.phrma.org/issues/researchdev/. Accessed October 8, 2003.
7. Sung NS, Crowley WF Jr, Genel M, et al. Central challenges facing the national clinical research enterprise. JAMA. 2003;289:1278-1287.
8. Jha AK, Perlin JB, Kizer KW, Dudley RA. Effect of the transformation of the Veterans Affairs Health Care System on the quality of care. N Engl J Med. 2003;348:2218-2227.
9. Wagner EH, Glasgow RE, Davis C, et al. Quality improvement in chronic illness care: a collaborative approach. Jt Comm J Qual Improv. 2001;27:63-80.
10. Berwick D, Rothman M. Pursuing perfection: an interview with Don Berwick and Michael Rothman. Interview by Andrea Kabcenell and Jane Roessner. Jt Comm J Qual Improv. 2002;28:268-278, 209.
11. Solberg LI, Hroscikoski MC, Sperl-Hillen JM, O'Connor PJ, Crabtree BF. Key issues in transforming health care organizations for quality: the case of advanced access. Jt Comm J Qual Saf. 2004;30:15-24.
12. Becher EC, Chassin MR. Improving the quality of health care: who will lead? Health Aff (Millwood). 2001;20:164-179.
13. Berwick DM. Disseminating innovations in health care. JAMA. 2003;289:1969-1975.
14. Chassin MR. Is health care ready for Six Sigma quality? Milbank Q. 1998;76:565-591, 510.
15. Committee on the Consequences of Uninsurance, Board on Health Care Services, Institute of Medicine. Care Without Coverage: Too Little, Too Late. Washington, DC: National Academy Press; 2002.
16. Clancy CM. AHRQ's FY 2005 budget request: new mission, new vision. Health Serv Res. 2004;39:xi-xviii.
17. DiMasi JA, Hansen RW, Grabowski HG. The price of innovation: new estimates of drug development costs. J Health Econ. 2003;22:151-185.
18. Public Citizen. Rx R&D Myths: The Case Against The Drug Industry's R&D "Scare Card." 2001. Available at: http://www.citizen.org/ publications/ release.cfm?ID=7065.
19. Berwick DM. Crossing the boundary: changing mental models in the service of improvement. Int J Qual Health Care. 1998;10:435-441.
20. Gillon R. Utilitarianism. Br Med J (Clin Res Ed). 1985;290:1411-1413.
21. Agency for Healthcare and Research Quality. Translating Research Into Practice (TRIP)-II. Fact sheet. Rockville, Md: AHRQ; 2001. Available at: http://www.ahrq.gov/research/trip2fac.htm.
22. Thomson O'Brien MA, Oxman AD, Davis DA, et al. Educational outreach visits: effects on professional practice and health care outcomes. Cochrane Database Syst Rev. 2000:CD000409.
23. Bennett JW, Glasziou PP. Computerised reminders and feedback in medication management: a systematic review of randomised controlled trials. Med J Aust. 2003;178:217-222.
24. Committee on Quality of Health Care in America, Institute of Medicine. Crossing the Quality Chasm: A New Health System for the 21st Century. Washington, DC: National Academy Press; 2001.
25. Shortell SM, Gillies RR, Anderson DA. Remaking Health Care in America. 2nd ed. San Francisco, Calif: Jossey-Bass; 2000.
26. Bodenheimer T, Wagner EH, Grumbach K. Improving primary care for patients with chronic illness. JAMA. 2002;288:1775-1779.
27. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ. 2002;324:71-86.
28. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet. 2002;360:7-22.
29. Sacks FM, Pfeffer MA, Moye LA, et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. N Engl J Med. 1996;335:1001-1009.
30. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group. N Engl J Med. 1998;339:1349-1357.
31. Jones PH, Davidson MH, Stein EA, et al. Comparison of the effi cacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR* Trial). Am J Cardiol. 2003;92:152-160.
32. Miller NH, Hill M, Kottke T, Ockene IS. The multilevel compliance challenge: recommendations for a call to action. A statement for healthcare professionals. Circulation. 1997;95:1085-1090.
33. Stamos TD, Shaltoni H, Girard SA, Parrillo JE, Calvin JE. Effectiveness of chart prompts to improve physician compliance with the National Cholesterol Education Program guidelines. Am J Cardiol. 2001;88:1420-1423, A1428.
34. McKillop T. The statin wars [letter]. Lancet. 2003;362:1498.
35. Jacobson TA, Griffiths GG, Varas C, et al. Impact of evidence-based "clinical judgment" on the number of American adults requiring lipid-lowering therapy based on updated NHANES III data. National Health and Nutrition Examination Survey. Arch Intern Med. 2000;160:1361-1369.
36. Pearson TA, Feinberg W. Behavioral issues in the efficacy versus effectiveness of pharmacologic agents in the prevention of cardiovascular disease. Ann Behav Med. 1997;19:230-238.
37. Noonan D. You want statins with that? Newsweek. July 14, 2003:34-48.
38. Barnett M. Pill profi ts. US News and World Report. December 22, 2003;135:40.
39. Kerlikowske K, Smith-Bindman R, Sickles EA. Short-interval followup mammography: are we doing the right thing? J Natl Cancer Inst. 2003;95:418-419.
40. Ostbye T, Greenberg GN, Taylor DH Jr, Lee AM. Screening mammography and Pap tests among older American women 1996-2000: results from the Health and Retirement Study (HRS) and Asset and Health Dynamics Among the Oldest Old (AHEAD). Ann Fam Med. 2003;1:209-217.
41. Health, United States, 2003 With Chartbook on Trends in the Health of Americans. Hyattsville, Md: National Center for Health Statistics; 2003. Available at: http://www.cdc.gov/nchs/data/hus/hus03.pdf. Accessed September 6, 2005.
42. Murray CJL, Evans DB, eds. Health Systems Performance Assessment: Debates, Methods and Empiricism. Geneva, Switzerland: World Health Organization; 2003.
43. Stevens A, Raftery J, eds. Health Care Needs Assessment. Oxford, England: Radcliffe Medical Press; 1997.
44. Unal B, Critchley JA, Fidan D, Capewell S. Life-years gained from modern cardiological treatments and population risk factor changes in England and Wales, 1981-2000. Am J Public Health. 2005;95:103-108.
45. Leatherman S, Berwick D, Iles D, et al. The business case for quality: case studies and an analysis. Health Aff (Millwood). 2003;22:17-30.
46. Herper M. Statin makers bet big on imaging technique. Forbes. November 10, 2003. Available at: http://www.forbes.com/home_ europe/2003/11/10/ cx_mh_1110merck.html.
47. Barrett A, Carey J. A bare knuckle battle over cholesterol drugs. Business Week. July 21, 2003:28.
48. Foster G. Bears sink teeth into AstraZeneca. This Is London. November 11, 2003. Available at: http://www.thisislondon.co.uk/news/business/articles/ timid70360?source=.
49. Gergen and McCurry advise on politics of health care policy: poll confi rms public's "insatiable appetite" for information on medical technology. Presented at: 26th Annual Meeting of the Health Industry Manufacturers Association; March 25, 2000. Available at: http:// www.advamed.org/2000annualmeeting/newstories.html. Accessed April 4, 2005.
50. Milstein A, Adler NE. Out of sight, out of mind: why doesn't widespread clinical quality failure command our attention? Health Aff (Millwood). 2003;22:119-127.
51. Medicare program: Negotiated rulemaking: Coverage and administrative policies for clinical diagnostic laboratory services; final rule. CFR 42 66: 410: 58788-58836. Available at: http://cms.hhs.gov/ncd/lab1.pdf.
52. Meadows M. The FDA's drug review process: ensuring drugs are safe and effective. FDA Consumer Magazine. July-August 2002. FDA publication No. 02-3242.
53. Smith R, Hiatt H, Berwick D. Shared ethical principles for everybody in health care: a working draft from the Tavistock group. BMJ. 1999;318:248-251.
54. Adams K, Corrigan JM, eds. Committee on Identifying Priority Areas for Quality Improvement. Board on Health Care Services, Institute of Medicine. Priority Areas for National Action: Transforming Health Care Quality. Washington, DC: National Academies Press; 2003.
55. Corrigan JM, Greiner A, Erickson SM, eds. Committee on Rapid Advance Demonstration Projects: Health Care Finance and Delivery Systems, Institute of Medicine. Fostering Rapid Advances in Health Care: Learning from System Demonstrations. Washington, DC: National Academies Press; 2002.
56. Committee on the Consequences of Uninsurance, Board on Health Care Services, Institute of Medicine. Insuring America's Health: Principles and Recommendations. Washington, DC: National Academies Press; 2004.
57. Himmelstein DU, Warren E, Thorne D, Woolhandler S. MarketWatch: Illness and injury as contributors to bankruptcy. Health Aff (Millwood). February 2, 2005 [Web exclusive]. Available at: http://content. healthaffairs.org/cgi/ reprint/hlthaff.w5.63v1. Accessed September 6, 2005.
58. Martin JC, Avant RF, Bowman MA, et al. The future of family medicine: a collaborative project of the family medicine community. Ann Fam Med. 2004;2(Suppl 1):S3-S32.
59. Murray M, Bodenheimer T, Rittenhouse D, Grumbach K. Improving timely access to primary care: case studies of the advanced access model. JAMA. 2003;289:1042-1046.
60. Car J, Sheikh A. Email consultations in health care: 1 - scope and effectiveness. BMJ. 2004;329:435-438.
61. Bodenheimer T, Grumbach K. Electronic technology: a spark to revitalize primary care? JAMA. 2003;290:259-264.
62. Glasgow RE, Bull SS, Piette JD, Steiner JF. Interactive behavior change technology: a partial solution to the competing demands of primary care. Am J Prev Med. 2004;27:80-87.
63. Safran DG. Defining the future of primary care: what can we learn from patients? Ann Intern Med. 2003;138:248-255.
64. Murphy J, Chang H, Montgomery JE, Rogers WH, Safran DG. The quality of physician-patient relationships: patients' experiences 1996-1999. J Fam Pract. 2001;50:123-129.
65. The Kaiser Family Foundation/Agency for Healthcare Research and Quality/Harvard School of Public Health. National Survey on Consumers' Experiences With Patient Safety and Quality Information. Washington, DC: Henry J. Kaiser Family Foundation; 2004. Publication No. 7209.
66. Kuzel AJ, Woolf SH, Gilchrist VJ, et al. Patient reports of preventable problems and harms in primary health care. Ann Fam Med. 2004;2:333-340.
67. Coffield AB, Maciosek MV, McGinnis JM, et al. Priorities among recommended clinical preventive services. Am J Prev Med. 2001;21:1-9.
68. Woolf SH, George JN. Evidence-based medicine: interpreting studies and setting policy. Hematol Oncol Clin North Am. 2000;14:761-784.
69. Kohn LT, Corrigan JM, Donaldson MS, eds. Committee on Quality of Health Care in America, Institute of Medicine. To Err is Human: Building a Safer Health System. Washington, DC: National Academies Press; 2000.
70. Szilagyi PG, Bordley C, Vann JC, et al. Effect of patient reminder/recall interventions on immunization rates: a review. JAMA. 2000;284:1820-1827.
71. Schmittdiel J, McMenamin SB, Halpin HA, et al. The use of patient and physician reminders for preventive services: results from a National Study of Physician Organizations. Prev Med. 2004;39:1000-1006.
72. Nielsen-Bohlman L, Panzer AM, Kindig DA, eds. Committee on Health Literacy, Board on Neuroscience and Behavioral Health, Institute of Medicine. Health Literacy: A Prescription to End Confusion. Washington, DC: National Academies Press; 2004.
73. Committee on Communication for Behavior Change in the 21st Century: Improving the Health of Diverse Populations, Board on Neuroscience and Behavioral Health, Institute of Medicine. Speaking of Health: Assessing Health Communication Strategies for Diverse Populations. Washington, DC: National Academies Press; 2002.
74. Gallagher A. Dignity and respect for dignity-two key health professional values: implications for nursing practice. Nurs Ethics. 2004;11:587-599.
75. Gruen RL, Pearson SD, Brennan TA. Physician-citizens-public roles and professional obligations. JAMA. 2004;291:94-98.
76. Dickey LL, Gemson DH, Carney P. Office system interventions supporting primary care-based health behavior change counseling. Am J Prev Med. 1999;17:299-308.